tiprankstipranks
Sonoma Pharmaceuticals (SNOA)
NASDAQ:SNOA
US Market
SNOA
Sonoma Pharmaceuticals
RESEARCH TOOLSreports
Want to see SNOA full AI Analyst Report?

Sonoma Pharmaceuticals (SNOA) Financial Statements

350 Followers

Sonoma Pharmaceuticals Financial Overview

Sonoma Pharmaceuticals's market cap is currently $5.50M. The company's EPS TTM is $-1.89; its P/E ratio is -0.58; Sonoma Pharmaceuticals is scheduled to report earnings on June 16, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Jun 22
Income Statement
Total Revenue$ 19.53M$ 14.29M$ 12.73M$ 13.27M$ 12.63M
Gross Profit$ 7.42M$ 5.46M$ 4.75M$ 4.48M$ 3.99M
Operating Income$ -2.46M$ -3.71M$ -4.70M$ -4.57M$ -5.89M
EBITDA$ -2.46M$ -2.77M$ -4.86M$ -5.06M$ -5.22M
Net Income$ -3.17M$ -3.46M$ -4.83M$ -5.15M$ -5.09M
Balance Sheet
Cash & Short-Term Investments$ 2.40M$ 5.37M$ 3.13M$ 3.82M$ 7.40M
Total Assets$ 13.96M$ 13.69M$ 14.74M$ 16.23M$ 18.84M
Total Debt$ 842.00K$ 305.00K$ 608.00K$ 849.00K$ 1.37M
Net Debt$ -1.56M$ -5.07M$ -2.52M$ -2.97M$ -6.03M
Total Liabilities$ 10.87M$ 9.28M$ 8.60M$ 8.25M$ 10.15M
Stockholders' Equity$ 3.10M$ 4.41M$ 6.14M$ 7.98M$ 8.70M
Cash Flow
Free Cash Flow$ -4.13M$ -168.00K$ -2.42M$ -6.42M$ -4.38M
Operating Cash Flow$ -3.93M$ -88.00K$ -2.40M$ -6.15M$ -4.25M
Investing Cash Flow$ -192.00K$ -80.00K$ -2.00K$ -258.00K$ -99.00K
Financing Cash Flow$ 477.00K$ 3.03M$ 1.68M$ 2.49M$ 7.40M
Currency in USD

Sonoma Pharmaceuticals Earnings and Revenue History

Income Statement >

Sonoma Pharmaceuticals Debt to Assets

Balance Sheet >

Sonoma Pharmaceuticals Cash Flow

Cash Flow >

Sonoma Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >